AstraZeneca PLC (AZN) |
|
47.37 -0.45 (-0.94%)
|
11-14 16:00 |
|
Open: |
47.45 |
Pre. Close: |
47.82 |
|
High:
|
47.51 |
Low:
|
47.11 |
|
Volume:
|
1,491,636 |
Market Cap:
|
122193M |
|
|
|
|
AstraZeneca PLC belongs to the healthcare sector. The company develops and markets pharmaceutical products for various therapeutic classes such as gastrointestinal, cardiovascular, respiratory, cancer, immunology, and neuroscience. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
47.566 - 47.816 |
47.816 - 48.029 |
|
Low:
|
46.517 - 46.805 |
46.805 - 47.051 |
|
Close:
|
46.898 - 47.386 |
47.386 - 47.801 |
|
Technical analysis |
as of: 2019-11-14 4:27:22 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 57.49 One year: 67.15 |
| Support: |
Support1: 45.71  Support2: 43.54 |
| Resistance: |
Resistance1: 49.22 Resistance2: 57.49 |
| Pivot: |
47.69 |
| Moving Average: |
MA(5): 47.28 MA(20): 46.94
MA(100): 44.02 MA(250): 41.14 |
| MACD: |
MACD(12,26): 0.72 Signal(9): 0.83 |
| Stochastic oscillator: |
%K(14,3): 48.33 %D(3): 54.14 |
| RSI: |
RSI(14): 57.21 |
| 52-week: |
High: 49.22 Low: 35.30 Change(%): 14.4 |
| Average Vol(K): |
3-Month: 321119 10-Days: 292301 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.AZN has closed above bottom band by 38.2%. Bollinger Bands are 27.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Fri, 15 Nov 2019 07:23:47 +0000
AstraZeneca: European Commission Approves Qtrilmet For Type-2 Diabetes
Thu, 14 Nov 2019 07:33:28 +0000
AZN:FDA Accepts Regulatory Submission For Selumetinib In Neurofibromatosis Type1
Tue, 12 Nov 2019 08:08:56 +0000
AstraZeneca Reports Positive TULIP 2 Trial For Anifrolumab To Treat SLE
Mon, 11 Nov 2019 16:04:42 +0000
Here’s Why FibroGen’s Stock Popped Friday
Mon, 11 Nov 2019 07:29:29 +0000
AstraZeneca: Roxadustat Phase III Pooled Analyses Show Positive Efficacy
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: New York Stock Exchange |
| Sector: Healthcare |
| Industry: Drug Manufacturers - Major |
| Shares Out. (M) |
2620.00 |
| Shares Float (M) |
2620.00 |
|
% Held by Insiders
|
0.01 |
|
% Held by Institutions
|
19.37 |
|
Shares Short (K)
|
13510 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
0.800 |
|
Book Value (p.s.)
|
4.640 |
|
PEG Ratio
|
1.53 |
|
Profit Margin
|
8.52 |
|
Operating Margin
|
6.09 |
|
Return on Assets (ttm)
|
1.5 |
|
Return on Equity (ttm)
|
14.4 |
|
Qtrly Rev. Growth
|
20.0 |
|
Gross Profit (p.s.)
|
6.714 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
1.615 |
|
Qtrly Earnings Growth
|
-30.60 |
|
Operating Cash Flow (M)
|
3820.00 |
|
Levered Free Cash Flow (M)
|
5830.00 |
Stock Valuations |
|
P/E
|
59.21 |
|
P/E Growth Ratio
|
-0.01 |
|
P/BV
|
10.21 |
|
P/S
|
5.06 |
|
P/CF
|
32.49 |
Dividends & Splits |
|
Dividend
|
2.800 |
|
Dividend Yield
|
0.06 |
|
Dividend Pay Date
|
2019-09-09 |
|
Ex-Dividend Date
|
2019-08-08 |
|
Forward Dividend
|
1.400 |
|
Last Split Date
|
2015-07-27 |
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
